Finished Dose Formulations

Finished Dose Formulations
Product Description

6 state-of-the-art manufacturing sites globally. Our manufacturing operations are focused on producing generics, branded generics, specialty, over-the-counter (OTC) products, oncology.

Major manufacturing partnerships with major global pharmaceutical companies such as Pfizer, Merck, GSK, Lagap, Abbott among many others.

Over 200 Products in different dosage forms:

  • Controlled release tablets
  • Mouth dissolving tablets
  • Effervescent tablets
  • Bi-layered tablets
  • Enteric coated pellets
  • Dry syrups
  • Suspension
  • Pellet in capsule
  • Powder in capsule
  • Sachets
  • Soft Gel Capsules

Neopharma

  • AE
  • 2015
    On CPHI since
Specifications
  • Supplied from
    Brazil; India; Japan; United Arab Emirates; United States

Neopharma

  • AE
  • 2015
    On CPHI since

More Products from Neopharma (2)

  • Active Pharmaceutical Ingredients (API)

    Product Active Pharmaceutical Ingredients (API)

    Neopharma supplies NCEs, cGMP intermediates and KSMs to global innovators. It is equipped with flexible, versatile and advanced infrastructure, tailored to fit any complex chemistry molecules. Our API manufacturing facilities comply with all regulatory guidelines and requirements of current Good Manufacturing...
  • Research & Development

    Product Research & Development

    Manufacturing Research: 

    Over 200 products in 8 therapeutic categories available in various dosage forms including:
    • Controlled release tablets • Mouth dissolving tablets • Effervescent tablets • Bi-layered tablets • Enteric coated pellets • Dry syrups • SuspensionPellet in ca...